SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/F06E0476A5005151AE3452D7E38E66B4D0B874B43D37ABB50B8A1953BD17E9091F4A6F3195FAC0201D1D8494E89FFE24>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/F06E0476A5005151AE3452D7E38E66B4D0B874B43D37ABB50B8A1953BD17E9091F4A6F3195FAC0201D1D8494E89FFE24
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/F06E0476A5005151AE3452D7E38E66B4D0B874B43D37ABB50B8A1953BD17E9091F4A6F3195FAC0201D1D8494E89FFE24
http://www.w3.org/2000/01/rdf-schema#comment
"furanocoumarins represent a novel group of TRPV1 modulators that may become important lead compounds in the drug discovery process aimed at developing new treatments for pain management."
xsd:string
http://purl.uniprot.org/uniprot/#_8D7EDF4E73B0677462875DC97FAE550130035BFF53B7CF15589D1E18AF33DCC4DC8A5018E13A706A6BB4FAC69CA8A94F
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/F06E0476A5005151AE3452D7E38E66B4D0B874B43D37ABB50B8A1953BD17E9091F4A6F3195FAC0201D1D8494E89FFE24
http://purl.uniprot.org/uniprot/Q8NER1
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/F06E0476A5005151AE3452D7E38E66B4D0B874B43D37ABB50B8A1953BD17E9091F4A6F3195FAC0201D1D8494E89FFE24
http://purl.uniprot.org/uniprot/#_Q8NER1-mappedCitation-24569998
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/F06E0476A5005151AE3452D7E38E66B4D0B874B43D37ABB50B8A1953BD17E9091F4A6F3195FAC0201D1D8494E89FFE24